| #201 |
Michael Joseph Daley |
American Cyanamid |
5 |
| #201 |
Ingo Schmuecking |
Siemens Healthineers Ag |
5 |
| #201 |
Gerard G. Sonenstein |
Colgate-Palmolive |
5 |
| #201 |
Kendall Carey |
Genentech |
5 |
| #201 |
Andrew J. Nitkin |
— |
5 |
| #201 |
KehDih Lai |
Regeneron Pharmaceuticals |
5 |
| #201 |
Jennifer Lynn Petoff |
Rohm And Haas |
5 |
| #201 |
H. Dalton King |
Bristol-Myers Squibb |
5 |
| #201 |
Neena Tierney |
Johnson & Johnson |
5 |
| #201 |
Kenneth Wright |
Domnick Hunter Limited |
5 |
| #201 |
Steven C. Dilliplane |
AMD |
5 |
| #201 |
Marc Santoro |
Bristol-Myers Squibb |
5 |
| #201 |
Gerald D. Ferguson |
US Air Force |
5 |
| #201 |
James Grimmer |
The Toronto-Dominion Bank |
5 |
| #201 |
David Wright |
— |
5 |
| #201 |
Donald W. Gates |
American Cyanamid |
5 |
| #201 |
Steven J. Shute |
AT&T |
5 |
| #201 |
Stuart T. Jolly |
Rca |
5 |
| #201 |
John J. Appolonia |
The Boc Group Limited |
5 |
| #201 |
Daniel A. Wachspress |
Continuum Dynamics |
5 |
| #201 |
Anil N. Namboodiripad |
Dr. Reddy'S Laboratories Limited |
5 |
| #201 |
Parag Sapre |
Covidien Lp |
5 |
| #201 |
Peter M. Dierks |
American Cyanamid |
5 |
| #201 |
Howard Y. Yuh |
— |
5 |
| #201 |
Edward Matelan |
Pfizer |
5 |
| #201 |
Ketan Patel |
Georgia Tech Research |
5 |
| #201 |
Alan Cole |
Citibank, N.A. |
5 |
| #201 |
Blaik P. Halling |
Fmc |
5 |
| #201 |
Philip Cooper |
Johnson & Johnson |
5 |
| #201 |
David E. Auslander |
Rorer Pharmaceutical |
5 |
| #231 |
Gregory Hollin |
Johnson & Johnson |
4 |
| #231 |
San Ardi Lee |
Morton Thiokol |
4 |
| #231 |
Lawrence Low |
Baytsp.Com |
4 |
| #231 |
Huji Tuerdi |
Bristol-Myers Squibb |
4 |
| #231 |
George Vratsanos |
Bristol-Myers Squibb |
4 |
| #231 |
Daniel Korey |
Ortho-Mcneil Pharmaceutical |
4 |
| #231 |
Richard Grzeczkowski |
General Instrument |
4 |
| #231 |
Christine M. Razler |
Johnson & Johnson |
4 |
| #231 |
Andrea C. Harriman |
Texas Instruments |
4 |
| #231 |
Mark D. Kuhn, IV |
Unknown |
4 |
| #231 |
Cezar Pendus |
IBM |
4 |
| #231 |
Ryan Edward Sullivan |
Bwt Property |
4 |
| #231 |
Steven Van Jackson |
IBM |
4 |
| #231 |
Craig R. Fairchild |
Bristol-Myers Squibb |
4 |
| #231 |
Philip J. Oaten |
Global Healthcare Exchange |
4 |
| #231 |
Jonathan P. MacGahan |
Lockheed Martin |
4 |
| #231 |
Jenny Zilberberg |
Trustees Of The Stevens Institute Of Technology |
4 |
| #231 |
Vincent J. Spadafora |
Fmc |
4 |
| #231 |
Thomas M. Razler |
Bristol-Myers Squibb |
4 |
| #231 |
Larry E. Hoch |
ExxonMobil |
4 |